Decreased monocyte calcium sensing receptor expression in patients with chronic kidney disease is associated with impaired monocyte ability to reduce vascular calcification-Reference-Cited by-同舟云学术

Decreased monocyte calcium sensing receptor expression in patients with chronic kidney disease is associated with impaired monocyte ability to reduce vascular calcification

Published:2021-06 Issue:6 Volume:99 Page:1382-1391
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Mary Aurélien,Objois Thibaut,Brazier Michel,Bennis Youssef,Boudot Cédric,Lenglet Gaëlle,Paccou Julien,Bugnicourt Jean-Marc,Choukroun Gabriel,Drueke Tilman B.,Massy Ziad A.,Kamel Saïd,Six Isabelle,Mentaverri Romuald

Publisher

Elsevier BV

Subject

Nephrology

Reference45 articles.

1. The calcium-sensing receptor in physiology and in calcitropic and noncalcitropic diseases;Hannan;Nat Rev Endocrinol,2018

2. Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism;Gogusev;Kidney Int,1997

3. Development and progression of secondary hyperparathyroidism in chronic kidney disease: lessons from molecular genetics;Goodman;Kidney Int,2007

4. Extracellular calcium-sensing receptor mediated signalling is involved in human vascular smooth muscle cell proliferation and apoptosis;Molostvov;Cell Physiol Biochem,2008

5. Calcium-sensing receptor as a potential modulator of vascular calcification in chronic kidney disease;Caudrillier;J Nephrol,2010

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Récepteur sensible au calcium (CaSR) et troubles minéraux et osseux de la maladie rénale chronique (TMO-MRC) : cibler seulement le CaSR parathyroïdien, est-ce suffisant ?;Bulletin de l'Académie Nationale de Médecine;2023-08

2. Subtotal Nephrectomy Associated with a High-Phosphate Diet in Rats Mimics the Development of Calcified Aortic Valve Disease Associated with Chronic Renal Failure;Journal of Clinical Medicine;2023-02-15

3. Artificial intelligence–guided precision treatment of chronic kidney disease – mineral bone disorder;CPT: Pharmacometrics & Systems Pharmacology;2022-08-03

4. Role of Calcimimetics in Treating Bone and Mineral Disorders Related to Chronic Kidney Disease;Pharmaceuticals;2022-07-31

5. Myeloid leukocytes’ diverse effects on cardiovascular and systemic inflammation in chronic kidney disease;Basic Research in Cardiology;2022-07-27